Hanspeter Egger

607 total citations
14 papers, 478 citations indexed

About

Hanspeter Egger is a scholar working on Pathology and Forensic Medicine, Hepatology and Epidemiology. According to data from OpenAlex, Hanspeter Egger has authored 14 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 4 papers in Hepatology and 3 papers in Epidemiology. Recurrent topics in Hanspeter Egger's work include Hepatitis C virus research (4 papers), Multiple Sclerosis Research Studies (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Hanspeter Egger is often cited by papers focused on Hepatitis C virus research (4 papers), Multiple Sclerosis Research Studies (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Hanspeter Egger collaborates with scholars based in Switzerland, United Kingdom and France. Hanspeter Egger's co-authors include Antoine Hadengue, Laura Rubbia‐Brandt, Jean‐Louis Frossard, Anne‐Laure Rougemont, Jérôme Pugin, Laurent Spahr, Emile Giostra, María Isabel Fischer, Pascal Küster and Nicole Mueller‐Lenke and has published in prestigious journals such as Gastroenterology, NeuroImage and Brain Research.

In The Last Decade

Hanspeter Egger

14 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hanspeter Egger Switzerland 10 239 213 144 53 51 14 478
Kazuyasu Maruyama Japan 12 43 0.2× 218 1.0× 45 0.3× 45 0.8× 18 0.4× 27 532
C Pezzoli Italy 9 26 0.1× 80 0.4× 74 0.5× 95 1.8× 32 0.6× 18 447
Katsuyoshi Higashi Japan 7 163 0.7× 100 0.5× 33 0.2× 12 0.2× 5 0.1× 22 443
Vincent Nuyens Belgium 12 90 0.4× 51 0.2× 12 0.1× 18 0.3× 8 0.2× 32 410
A. Herrero-San Martín Spain 5 55 0.2× 470 2.2× 103 0.7× 6 0.1× 5 0.1× 6 623
Jianjun Liu China 11 30 0.1× 80 0.4× 16 0.1× 8 0.2× 39 0.8× 29 378
Jie Han China 12 43 0.2× 74 0.3× 22 0.2× 14 0.3× 5 0.1× 29 434
Ana M. Tormos Spain 10 19 0.1× 131 0.6× 42 0.3× 6 0.1× 12 0.2× 14 601
Dabing Huang China 15 53 0.2× 75 0.4× 26 0.2× 5 0.1× 7 0.1× 30 534
Renee Wong United States 14 148 0.6× 58 0.3× 8 0.1× 8 0.2× 12 0.2× 20 623

Countries citing papers authored by Hanspeter Egger

Since Specialization
Citations

This map shows the geographic impact of Hanspeter Egger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanspeter Egger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanspeter Egger more than expected).

Fields of papers citing papers by Hanspeter Egger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanspeter Egger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanspeter Egger. The network helps show where Hanspeter Egger may publish in the future.

Co-authorship network of co-authors of Hanspeter Egger

This figure shows the co-authorship network connecting the top 25 collaborators of Hanspeter Egger. A scholar is included among the top collaborators of Hanspeter Egger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanspeter Egger. Hanspeter Egger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Bendfeldt, Kerstin, Hanspeter Egger, Niklaus Denier, et al.. (2010). Spatiotemporal distribution pattern of white matter lesion volumes and their association with regional grey matter volume reductions in relapsing‐remitting multiple sclerosis. Human Brain Mapping. 31(10). 1542–1555. 38 indexed citations
2.
Bendfeldt, Kerstin, Hanspeter Egger, Thomas E. Nichols, et al.. (2010). Effect of immunomodulatory medication on regional gray matter loss in relapsing–remitting multiple sclerosis—A longitudinal MRI study. Brain Research. 1325. 174–182. 29 indexed citations
3.
Bendfeldt, Kerstin, Pascal Küster, Hanspeter Egger, et al.. (2008). Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis — A longitudinal voxel-based morphometry study. NeuroImage. 45(1). 60–67. 73 indexed citations
4.
Giostra, Emiliano, Gerd A. Kullak‐Ublick, Walter Keller, et al.. (2004). Ribavirin/interferon-a sequential treatment of recurrent hepatitis�C after liver transplantation. Transplant International. 17(4). 169–176. 39 indexed citations
5.
Giostra, Emiliano, Gerd A. Kullak‐Ublick, Walter Keller, et al.. (2004). Ribavirin/interferon-alpha sequential treatment of recurrent hepatitis C after liver transplantation. Transplant International. 17(4). 169–176. 26 indexed citations
6.
Spahr, Laurent, Laura Rubbia‐Brandt, Jean‐Louis Frossard, et al.. (2002). Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study. Journal of Hepatology. 37(4). 448–455. 153 indexed citations
7.
Ghielmini, Michele, S. Pampallona, Luca Gabutti, et al.. (2001). Phase I-II study of escalating doses of amifostine combined with high-dose cyclophosphamide. Cancer Chemotherapy and Pharmacology. 47(6). 532–536. 5 indexed citations
8.
Meili, Esther, et al.. (2001). Ribavirin and interferon alpha-2b combination treatment of chronic hepatitis C is effective in patients with clotting disorders. Gastroenterology. 120(5). A382–A383. 6 indexed citations
9.
10.
Kochak, Gregory M., et al.. (1993). Prinomide Tromethamine Pharmacokinetics: Mutually Dependent Saturable and Competitive Protein Binding Between Prinomide and Its Own Metabolite. Pharmaceutical Research. 10(1). 49–55. 4 indexed citations
11.
Egger, Hanspeter, et al.. (1988). Disposition and metabolism of prinomide in laboratory animals.. Drug Metabolism and Disposition. 16(4). 568–575. 5 indexed citations
12.
Egger, Hanspeter, et al.. (1982). Metabolism of pirprofen in man, monkey, rat, and mouse.. Drug Metabolism and Disposition. 10(5). 529–536. 22 indexed citations
13.
Egger, Hanspeter, et al.. (1981). Metabolism of methylphenidate in dog and rat.. Drug Metabolism and Disposition. 9(5). 415–423. 25 indexed citations
14.
Egger, Hanspeter, et al.. (1977). Disposition of pirprofen, a new anti‐inflammatory drug. Clinical Pharmacology & Therapeutics. 21(6). 721–730. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuyasu Maruyama Breakdown of academic impact, for papers by C Pezzoli Breakdown of academic impact, for papers by Katsuyoshi Higashi Breakdown of academic impact, for papers by Vincent Nuyens Breakdown of academic impact, for papers by A. Herrero-San Martín Breakdown of academic impact, for papers by Jianjun Liu Breakdown of academic impact, for papers by Jie Han Breakdown of academic impact, for papers by Ana M. Tormos Breakdown of academic impact, for papers by Dabing Huang Breakdown of academic impact, for papers by Renee Wong
Rankless by CCL
2026